Delivery Order SPE2DR25D3015-SPE2DR26F4EW4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,313.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a December 10, 2025 completion date. This contract represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The award was executed on December 9, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,845.70 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 4, 2025, with completion scheduled for December 5, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,059.05 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of December 2, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $77,518.39. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be sourced from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $18,893.52 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 3, 2025. The contract is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,522.24 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.29 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on September 26, 2025, with completion expected by September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $9,591.59 on September 26, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed price, non-set-aside delivery order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a ceiling value of $2,696.06. This is a firm fixed-price, non-set-aside delivery order with a completion date of June 3, 2025, with performance to be fulfilled at the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4EW4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 24, 2025, with an ultimate completion date of November 25, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.99 million through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including products for the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capacity as a major pharmaceutical distributor serving critical federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/23/25 |